ATE391515T1 - Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker - Google Patents

Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker

Info

Publication number
ATE391515T1
ATE391515T1 AT00902334T AT00902334T ATE391515T1 AT E391515 T1 ATE391515 T1 AT E391515T1 AT 00902334 T AT00902334 T AT 00902334T AT 00902334 T AT00902334 T AT 00902334T AT E391515 T1 ATE391515 T1 AT E391515T1
Authority
AT
Austria
Prior art keywords
gfp
tumor
contain
tumors
metastasis
Prior art date
Application number
AT00902334T
Other languages
English (en)
Inventor
Yuying Tan
Takashi Chishima
Original Assignee
Anticancer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22850696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE391515(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Anticancer Inc filed Critical Anticancer Inc
Application granted granted Critical
Publication of ATE391515T1 publication Critical patent/ATE391515T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
    • A61K49/0047—Green fluorescent protein [GFP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0097—Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
AT00902334T 1999-01-07 2000-01-07 Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker ATE391515T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/226,856 US6251384B1 (en) 1997-04-28 1999-01-07 Metastasis models using green fluorescent protein (GFP) as a marker

Publications (1)

Publication Number Publication Date
ATE391515T1 true ATE391515T1 (de) 2008-04-15

Family

ID=22850696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00902334T ATE391515T1 (de) 1999-01-07 2000-01-07 Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker

Country Status (8)

Country Link
US (3) US6251384B1 (de)
EP (1) EP1156833B1 (de)
JP (1) JP3709343B2 (de)
AT (1) ATE391515T1 (de)
AU (1) AU783517B2 (de)
CA (1) CA2358439C (de)
DE (1) DE60038544T2 (de)
WO (1) WO2000040274A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050005310A1 (en) * 1999-07-12 2005-01-06 Genentech, Inc. Expression vectors and methods
AU2001249297B2 (en) * 2000-03-17 2006-11-23 Anticancer, Inc. Whole-body optical imaging of gene expression and uses thereof
US7244232B2 (en) * 2001-03-07 2007-07-17 Biomed Solutions, Llc Process for identifying cancerous and/or metastatic cells of a living organism
JP2005520781A (ja) * 2001-07-09 2005-07-14 アンチキャンサー インコーポレーテッド 蛍光タンパク質をマーカーとして用いた感染の画像化
EP1281767A3 (de) 2001-07-31 2003-05-28 Aladar A. Szalay Lichtausstrahlende Mikroorganismen und Zellen für die Diagnose und Therapie von Tumoren
AU2002326872B2 (en) * 2001-09-10 2008-07-03 Anticancer, Inc. Enhanced resolution of tumor metastasis
AU2002367319B8 (en) * 2001-12-31 2008-03-06 Anticancer, Inc. System for monitoring bacterial tumor treatment
US7280680B2 (en) 2002-03-04 2007-10-09 Riken Method and apparatus for observing three-dimensional localizations of in vivo expressed genes as well as method and apparatus for observing minute three-dimensional localizations of in vivo expressed genes
US20030228261A1 (en) * 2002-06-05 2003-12-11 Aladar Szalay Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
EP1369491A1 (de) * 2002-06-05 2003-12-10 Aladar A. Szalay Lichtemittierende Mikroorganismen und Zellen für die Diagnose und Therapie von Krankheiten assoziiert mit Wunden oder entzündetem Gewebe
US7795493B2 (en) 2002-08-21 2010-09-14 Revivicor, Inc. Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferase
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US20050019925A1 (en) * 2002-11-14 2005-01-27 Genentech, Inc. Intron fusion construct and method of using for selecting high-expressing production cell lines
CA2515203C (en) * 2003-02-07 2015-11-24 Anticancer, Inc. Immunocompromised rodents as dual color tumor models
EP2363025A1 (de) 2003-03-27 2011-09-07 PTC Therapeutics, Inc. Betrachtung von Enzymen des TRNA-Splice-Wegs zur Identifikation von Antifungalen und/oder Proliferationshemmenden Molekülen
EP2319318A3 (de) 2003-03-27 2011-08-17 PTC Therapeutics, Inc. Verfahren zur Identifizierung von Verbindungen mit tRNA-Splicing Endonuklease als Aufhänger, und Verwendungen für diese Verbindungen als anti-Proliferationsmittel
EP1628996A4 (de) * 2003-05-27 2008-01-09 Anticancer Inc Abbildbares tiermodell einer sars-infektion
EP1631935A4 (de) * 2003-06-09 2008-10-15 Univ Singapore System und verfahren zur bereitstellung eines dienstes
SG179291A1 (en) * 2003-06-18 2012-04-27 Genelux Corp Modified recombinant vaccinia viruses and other microorganisms, uses thereof
US8634607B2 (en) 2003-09-23 2014-01-21 Cambridge Research & Instrumentation, Inc. Spectral imaging of biological samples
US7321791B2 (en) * 2003-09-23 2008-01-22 Cambridge Research And Instrumentation, Inc. Spectral imaging of deep tissue
US7155274B1 (en) 2003-11-21 2006-12-26 Imaging Diagnostic Systems, Inc. Optical computed tomography scanner for small laboratory animals
WO2005099363A2 (en) 2004-03-26 2005-10-27 Whitehead Institute For Biomedical Research Methods of diagnosing, preventing and treating cancer metastasis
JP2008507294A (ja) 2004-07-26 2008-03-13 ダウ グローバル テクノロジーズ インコーポレイティド 菌株遺伝子操作による改善されたタンパク質発現のための方法
CN101916359B (zh) 2005-01-27 2012-06-20 剑桥研究和仪器设备股份有限公司 把样本的不同区域分类到相应类别的方法和设备
WO2007035213A2 (en) 2005-08-09 2007-03-29 Revivicor, Inc. Transgenic ungulates expressing ctla4-ig and uses thereof
WO2007070784A2 (en) * 2005-12-12 2007-06-21 The Uab Research Foundation Fluorescent detection of cancer and fluorescent guided surgical removal
EP1840570A1 (de) 2006-03-31 2007-10-03 F. Hoffmann-La Roche Ag Tumormodell unter Verwendung von grünem Fluoreszenzprotein
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
US20090098529A1 (en) * 2006-10-16 2009-04-16 Nanhai Chen Methods for attenuating virus strains for diagnostic and therapeutic uses
US20100093061A1 (en) * 2006-12-20 2010-04-15 Bodie Elizabeth A Assays for Improved Fungal Strains
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
EP2142651B1 (de) 2007-04-27 2013-05-22 Pfenex Inc. Schnellscreeningverfahren für bakterienwirte zur identifizierung bestimmter stämme mit verbessertem ertrag und/oder verbesserter qualität bei der expression heterologer proteine
JP5213075B2 (ja) 2007-06-15 2013-06-19 ジェネラックス・コーポレイション 腫瘍の画像化および／または処置のための微生物
KR20100089839A (ko) * 2007-10-01 2010-08-12 안티캔서, 인코포레이티드 조영가능한 천식용 설치류 모델
US20120052003A9 (en) * 2008-05-16 2012-03-01 Szalay Aladar A Microorganisms for preventing and treating neoplasms accompanying cellular therapy
WO2010006168A2 (en) * 2008-07-09 2010-01-14 University Of Rochester Methods of treating cancer using and agent that modulates activity of the calcitonin-gene related peptide ("cgrp") receptor
WO2012142529A2 (en) 2011-04-15 2012-10-18 Genelux Corporation Clonal strains of attenuated vaccinia viruses and methods of use thereof
US8859256B2 (en) 2011-10-05 2014-10-14 Genelux Corporation Method for detecting replication or colonization of a biological therapeutic
JP6436669B2 (ja) * 2014-07-22 2018-12-12 国立大学法人福井大学 子宮肉腫転移モデル動物
CA3133728C (en) 2015-11-02 2023-10-24 Pura Scents, Inc. Scent dispensation
USD809116S1 (en) 2015-11-02 2018-01-30 Pura Scents Dispenser
USD816506S1 (en) 2015-11-02 2018-05-01 Pura Scents, Inc. Vial for a scent dispenser
US20200270557A1 (en) * 2017-09-18 2020-08-27 President And Fellows Of Harvard College Human in vitro orthotopic and metastatic models of cancer
CN116539862B (zh) * 2022-07-20 2024-03-12 成都诺医德医学检验实验室有限公司 一种基于类器官共生长平台测试肿瘤转移能力的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491084A (en) * 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
WO1997045550A2 (en) 1996-05-31 1997-12-04 Baxter International Inc. Mini-adenoviral vector
WO1998049336A1 (en) 1997-04-28 1998-11-05 Anticancer, Inc. Metastasis models using green fluorescent protein (gfp) as a marker

Also Published As

Publication number Publication date
JP3709343B2 (ja) 2005-10-26
CA2358439A1 (en) 2000-07-13
EP1156833B1 (de) 2008-04-09
US20040191173A1 (en) 2004-09-30
CA2358439C (en) 2010-06-29
EP1156833A1 (de) 2001-11-28
US6251384B1 (en) 2001-06-26
US20020026649A1 (en) 2002-02-28
US6759038B2 (en) 2004-07-06
JP2002534398A (ja) 2002-10-15
DE60038544D1 (de) 2008-05-21
DE60038544T2 (de) 2009-07-09
WO2000040274A1 (en) 2000-07-13
AU783517B2 (en) 2005-11-03
AU2406900A (en) 2000-07-24

Similar Documents

Publication Publication Date Title
ATE391515T1 (de) Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker
ATE398183T1 (de) Metastasemodelle unter verwendung des grün- fluoreszierenden proteins
CA2289283A1 (en) Metastasis models using green fluorescent protein (gfp) as a marker
Conklin et al. Fluorescence lifetime imaging of endogenous fluorophores in histopathology sections reveals differences between normal and tumor epithelium in carcinoma in situ of the breast
Daphu et al. In vivo animal models for studying brain metastasis: value and limitations
Liu et al. The histone methyltransferase EZH2 mediates tumor progression on the chick chorioallantoic membrane assay, a novel model of head and neck squamous cell carcinoma
Winnard Jr et al. Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer
WO2004092338A3 (en) Compositions, splice variants and methods relating to cancer specific genes and proteins
ES2179196T3 (es) Complejos radiofarmacos ternarios.
Hoffman Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins
Lee et al. In vivo imaging using polymeric nanoparticles stained with near-infrared chemiluminescent and fluorescent squaraine catenane endoperoxide
DE60131257D1 (de) Diffusionsbildgebung von gewebe
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
Sun et al. Preclinical advances with multiphoton microscopy in live imaging of skin cancers
ATE455853T1 (de) Antikörper gegen geschädigtes gewebe
Xin et al. Prognostic factors in malignant mixed tumors of the salivary gland: correlation of immunohistochemical markers with histologic classification
US20110296538A1 (en) In vivo quantitative screening test for anti-metastasis treatment efficacy
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
Alfano Advances in ultrafast time resolved fluorescence physics for cancer detection in optical biopsy
Tomas et al. Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma
CN107058299A (zh) 一种近红外荧光核酸银纳米簇及其制备方法和用途
ATE366936T1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
Lukacs et al. Epithelial stem cells of the prostate and their role in cancer progression
CN101619347B (zh) 特异识别肿瘤细胞的寡核苷酸配基bc15的应用
Nguyen et al. Microfluidic-assisted chromogenic in situ hybridization (MA-CISH) for fast and accurate breast cancer diagnosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties